Multiple myeloma is a clonal malignancy that contributes to about 10% of hematological malignancies. Treatment ranges from alkylators and corticosteroids to autologous stem cell transplantation in the advanced stages of the disease. Knowing the details of available treatment modalities and recent advancements in cancer pharmacotherapy is crucial for positive patient outcomes. Join renowned oncologist Dr.
Fady Nasr in an exclusive session on “Multiple Myeloma” on 5 th April 2023, 6:00 PM IST onwards. Stay tuned! Read more on multiple myeloma: FDA Approves Teclistamab-cqyv for Refractory Multiple Myeloma New Therapy for Hard-to-Treat Multiple Myeloma Vaccine-induced Immune Response in Multiple Myeloma and B-cell Lymphoma Patients Take this Quiz on Multiple Myeloma, HCC & Liver Surgery for Cancer
